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INTRODUCTION
Atherosclerotic plaque progression may lead to coronary
artery disease (1), stroke (2), peripheral artery disease (3), and
sudden cardiac death (SCD) (4) in humans. However, the me-
chanism of plaque growth, destabilization, and rupture has
not been fully established.
Atherosclerotic plaque assessment has been conducted in
the past using histopathology in autopsy specimens (5, 6).
Recently, serum biomarker studies (7, 8) and imaging stud-
ies such as computerized tomography (9), magnetic resonance
imaging (10), intima-media thickness (11), coronary angiog-
raphy (12), optical coherence tomography (13), intravascu-
lar ultrasound (IVUS) (14, 15), and virtual histology IVUS
(VH-IVUS) (16, 17) have been used to assess plaques. IVUS
and VH-IVUS are the most commonly used tools in the eval-
uation of vulnerable plaques.
Nogo-B (reticulon 4 B) has been recently discovered as a
member of the reticulon family of proteins. The biological
role of Nogo-B is not well understood. Some animal data sug-
gest that Nogo-B is associated with the promotion of endo-
thelial migration and the inhibition of vascular smooth mus-
cle cell migration, resulting in homeostasis and remodeling
of vascular structures (18). However, there is limited human
data, and the relationship between Nogo-B and the progres-
sion of fibroatheromas (FA) or vulnerable plaques is not well
understood. Thus, the purpose of this study was to evaluate
the relationship between Nogo-B, and FA or plaque progres-
sion in human coronary arteries using VH-IVUS.
MATERIALS AND METHODS
Definition of fibroatheromas
Early FA was defined as a necrotic core (NC) area of <0.1
mm2 and <10% in the presence of a plaque burden of >40%,
and late FA was defined as a NC area of 0.1-1.0 mm2 and
>10% of the NC area in the presence of a plaque burden of
>40% (19). Thin-cap FA (TCFA) was defined as a NC >10%
of the plaque area with a plaque burden of >40%, as well as
NC in contact with the lumen for at least 3 consecutive image
slices. Thick-cap FA (TkCFA) was defined as NC >10% of
the plaque area with a plaque burden of >40%, as well as
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Atherosclerotic Progression Attenuates the Expression of Nogo-B in
Autopsied Coronary Artery: Pathology and Virtual Histology 
Intravascular Ultrasound Analysis
The relation of Nogo-B to atherosclerotic plaque progression is not well understood.
Thus, the purpose of this study was to assess the expression of Nogo-B in fibro-
atheromas (FA) of different stages, classified using virtual histology intravascular
ultrasound (VH-IVUS) analysis in 19 autopsied cases of non-sudden cardiac death.
VH-IVUS imaging analysis was performed 30 mm from the ostium of each coronary
artery. VH-IVUS revealed 11 early FAs (34.5±8.3 yr), 12 late FAs (42.6±16.6 yr),
8 thick-cap FAs (TkCFAs) (46.4±11.1 yr), and 6 thin-cap FAs (TCFAs) (51.8±
6.8 yr). TkCFAs and TCFAs were defined as advanced FA. FA progression advan-
ced with age (P=0.04). VH-IVUS analysis of small, early FAs showed smaller necrot-
ic cores and relatively less calcium compared to more advanced FAs with large ne-
crotic cores (P<0.001). Histopathology and immunohistochemical stains demon-
strated that early or late FAs had smaller necrotic cores, less empty space of decal-
cification, and greater Nogo-B expression compared to advanced FAs (vs. early
FA, P=0.013; vs. late FA, P=0.008, respectively). These findings suggest that FA
progression is inversely associated with Nogo-B expression. Local reduction of
Nogo-B may contribute to plaque formation and/or instability.
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NC without contact with the lumen in the image slices (20).
TkCFA and TCFA were defined as advanced FA, in contrast
to early FA or late FA.
Study subjects
Human coronary arteries were collected from 22 autop-
sied samples at the National Institute of Scientific Investi-
gation in Korea. Autopsies were performed within 8 hr after
death, and the collected coronary arteries were immediately
stored in phosphate-buffered saline at 4℃. Three cases of
SCD were excluded from 22 autopsied samples because of a
difficulty in collection of SCD samples. Of them 26 coro-
nary arteries were also excluded because of failure to pass a
guide wire for IVUS. The other reasons of exclusion were
IVUS imaging artifact, inadequate pathology, and failure to
meet criteria (including overlapping) for a definition of early
or late FA. Ultimately, data were acquired from 31 coronary
arteries, and 37 lesions were analyzed. This study was appro-
ved by the institutional review board of the Chung-Ang Uni-
versity Medical Center.
VH-IVUS 
IVUS imaging was performed beginning from 50 mm dis-
tal to the left main coronary artery and right coronary artery
ostium in a bath of 0.9% saline at a temperature of 37℃. VH-
IVUS examination was performed with a dedicated console
(20 MHz, 2.9 F monorail, electronic Eagle Eye Gold IVUS
catheter, Volcano Therapeutics, Rancho Cordova, CA, U.S.A.).
The automated pull-back system had a speed of 0.5 mm/sec.
The time between death and IVUS imaging did not exceed
48 hr. All VH-IVUS images were recorded on a DVD-ROM
and later analyzed offline within 30 mm. 
Histopathology
Tissue samples were fixed in 10% buffered-formalin and
cut every 3 mm perpendicular to the long axis of the coro-
nary artery. They were then dehydrated in 70% ethanol, em-
bedded in paraffin, and cut at 3 μ m thickness using a micro-
tome. They were stained with hematoxylin-eosin (H-E) and
Masson’s trichrome for fibrosis and von Kossa stain for calci-
fication.
Immunohistochemistry
Embedded paraffin tissues were deparaffinized and rehy-
drated using xylene and ethanol. The sections were treated
with 0.5% H2O2 for 20 min and washed with distilled water.
After the sections were deposited with 10 mM citrate (pH
6.0) to suppress nonspecific binding of the antibodies and
cooled at room temperature to increase the exposure of anti-
gens, they were treated with TBS (pH 7.2-7.4) and incubated
with normal goat serum at room temperature to suppress en-
dogenous peroxidase activity. The sections were then reacted
with primary antibodies, such as anti-CD68 and anti-CD31
(Lab Vision Corp., Fremont, CA, U.S.A.), anti-neurite out-
growth inhibitor B (Nogo-B; Chemicon International Inc.,
Temecula, CA, U.S.A.), and anti-matrix metalloproteinase-
9 (MMP-9; Lab Vision Corp) at room temperature overnight
and washed with TBS. Biotin-conjugated secondary anti-
bodies (Zymed Laboratories Inc., South San Francisco, CA,
U.S.A.) were used along with the primary antibodies for 1
hr, after which the sections were treated with streptavidin-
peroxidase for 20 min. The sections were treated with AEC
(3-amino-9-ethylcarbazole) chromogen and counterstained
with Mayer’s hematoxylin, then assessed using light micro-
scopy. Control tissues were treated with normal serum.
VH-IVUS and histopathologic data analysis
VH-IVUS analysis was conducted by two experienced car-
diologists who were blinded to patient information. VH-IVUS
used spectral analysis of IVUS radiofrequency data to con-
struct tissue maps that correlated with a specific spectrum
of the radiofrequency signal. The contour of both the lumen
and the media-adventitia interface was identified using auto-
matic edge detection and was manually corrected when nec-
essary. VH-IVUS automatically classified the plaque into 4
major components: fibrous (labeled green color), fibro-fatty
(labeled greenish-yellow color), necrotic core (labeled red
color), and dense calcium (labeled white color). The ratio of
each plaque component was expressed as a percentage of the
total plaque volume and as an absolute area. 
Histopathologic analysis was performed by two patholo-
gists who were blinded to VH-IVUS information. SPOT
Insight 4MP firewell color 3-shot (Diagnostic instruments
Inc., Sterling Heights, MI, U.S.A.), SPOT software 4.6 and
BX51 microscope (Olymphus, Tokyo, Japan) was used for
computer-based morphometry. Each group was evaluated
by the quantitative analysis as areas of calcium and necrotic
core in plaques. The expression level of MMP-9 and CD68
were compared by the areas of the positive staining. Nogo-
B activity was analyzed as percentage of positive areas in the
total plaques. The numbers of CD31 positive microvessel,
microvessel densities, in the fibroatheromas were counted
on the medium power. 
Statistical analysis
Quantitative data are presented as means±standard devia-
tion (SD), and categorical data are expressed as frequencies.
Continuous variables were compared using the two-tailed
unpaired t-test for normally distributed variables and the
Mann-Whitney U-test for skewed distributed variables. AN-
OVAR testing was used to compare data among more than
three groups. Differences between categorical groups were598 W.-S. Lee, S.-W. Kim, S.-A. Hong, et al.
compared using the chi-square test. Simple correlations were
examined using Pearson’s coefficient of correlation for con-
tinuous variables. P values less than 0.05 (2-sided) were con-
sidered statistically significant. Statistical analyses were con-
ducted with SPSS software, version 11.5 (Statistical Package
for the Social Science, SPSS Inc., Chicago, IL, U.S.A.).
RESULTS
Study population
Demographic data and characteristics for the study popu-
lation are presented in Table 1. The mean age of the subjects
was 42.5±13.0 yr. Males made up 68% of the study popu-
lation. The distribution of analytic sites was as follows: left
anterior descending artery in 32% of subjects, left circumflex
artery in 36%, and right coronary artery in 32%. Non-car-
diac causes of death included fall injury (32%), stab wound
injury (21%), inhalation burn (21%), motor vehicle injury
(16%), and suicide (10%).
Atherosclerotic lesions by VH-IVUS
Coronary FAs were classified into 4 groups: early FA (n=
11), late FA (n=12), TkCFA (n=8), and TCFA (n=6), by VH-
IVUS (Fig. 1). There were significant differences in the mean
age of FA progression (early FA 34.5±8.3 yr, late FA 42.6
±16.6 yr, TkCFA 46.4±11.1 yr, and TCFA 51.8±6.8 yr,
respectively, P=0.04). However, the relationship between
NC and the age was not significant (r=0.087, P=0.609).
VH-IVUS analysis demonstrated that early FAs with small-
er necrotic core had also relatively less calcium (P<0.001)
compared to more advanced FAs with larger necrotic cores
(Table 2). Furthermore, the relative amounts of fibrotic and
fibrofatty tissue decreased as the necrotic core increased (r=
0.755, P<0.001 and r=0.667, P<0.001, respectively, figure
not shown), while the relative size of the dense calcium area
increased as the size of the necrotic core increased (r=0.739,
P<0.001, figure not shown). In comparison analysis between
TkCFA and TCFA, mean age (P=0.310), plaque burden (P=
0.594), percent of fibrofatty component (P=0.531), and NC
component (P=0.055) were not different, respectively. How-
ever, percent of fibrous component was lower (P<0.001) and
dense calcium was higher (P<0.001) in the TCFA rather than
TkCFA. Thus, VH-IVUS analysis showed that dense calcium
component might be associated with plaque progression in
addition to larger necrotic cores. 
Pathologic characteristics and immunohistochemical
activity
H-E staining with VH-IVUS analysis showed that advan-
Values are n (%).
LAD, left anterior descending artery; LCX, left circumflex artery; RCA,
right coronary artery.
Variables Number of subjects (n=19)
Age (yr) 42.5±13.0
Sex
Male 13 (68%)
Female 6 (32%)
Coronary artery
LAD 12 (32%)
LCX 13 (36%)
RCA 12 (32%)
Cause of death
Stab wound injury 4 (21%)
Fall down 6 (32%)
Motor vehicle injury 3 (16%)
Suicide 2 (10%)
Inhalation burn 4 (21%)
Table 1. Study population
F area 4.9 mm
2
FF area 1.0 mm
2
NC area 0.1 mm
2
DC area 0.0 mm
2
F area 6.0 mm
2
FF area 1.5 mm
2
NC area 0.4 mm
2
DC area 0.2 mm
2
F area 6.4 mm
2
FF area 1.0 mm
2
NC area 2.0 mm
2
DC area 0.8 mm
2
F area 2.5 mm
2
FF area 0.3 mm
2
NC area 2.3 mm
2
DC area 0.7 mm
2
Fig. 1. Classification of fibroatheromas by virtual histology intravascular ultrasound. Early fibroatheromas (A) had less extensively necrotic
cores (red color) and greater fibrous (green color) composition, while thick-cap fibroatheromas (C) and thin-cap fibroatheromas (D) had
larger necrotic cores and more extensive calcium (white color) deposition.
F, fibrous; FF, fibrofatty; NC, necrotic core; DC, dense calcium.
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ced FAs had larger necrotic cores than early FAs (P<0.001)
and late FAs (P<0.001) did (Fig. 2A, B, F, G; Fig. 3A). 
Von Kossa staining revealed increased plaque calcifications
and larger emptying spaces of decalcification in advanced FA
(Fig. 2C, H), but quantitative analysis did not demonstrate
a statistically significant difference (Fig. 3B).
Immunohistochemistry demonstrated that CD68-positive
macrophage infiltration was more significant in advanced
FA than it was in early FA (P=0.002) or late FA (P=0.001)
(Fig. 2D, I; Fig. 3C). MMP-9 activity was also increased in
advanced FA compared to early FA (P=0.013) and late FA
(P=0.018) (Fig. 2E, J; Fig. 3D). 
There were few CD31-positive microvessels in the plaques
in early FA and late FA, while there were more microvessels
in the plaques in TkCFA and TCFA (figure not shown). 
Pathology and VH-IVUS correlation
A correlation analysis between pathology and VH-IVUS
was performed in 37 coronary lesions. The NC areas of early
FA were 0.08±0.04 mm2 in VH-IVUS and 0.08±0.09
mm2 in the pathology respectively. The NC areas of late FA
were 0.35±0.17 mm2 in VH-IVUS and 0.15±0.23 mm2
in the pathology, respectively (Table 3). The correlation of
NC between VH-IVUS and pathology was r=0.71 (P=0.005)
(Fig. 4). Thirty-four of 37 FAs (94%) were matched correct-
Values are means±SD. ANOVAR was used to compare data between groups. P values <0.05 were considered statistically significant. 
FA, fibroatheroma; TkCFA, thick-cap fibroatheroma; TCFA, thin-cap fibroatheroma; EEL, external elastic lamina; F, fibrous; FF, fibro-fatty; NC, necrotic
core; DC, dense calcium.
Variables Early FA (n=11) Late FA (n=12) TkCFA (n=8) TCFA (n=6) P value
EEl area (mm
2) 9.29±2.47 8.72±2.27 11.40±2.46 12.81±1.42 0.003
Lumen area (mm
2) 4.31±1.45 4.38±1.09 4.51±1.21 5.29±0.91 0.419
Plaque area (mm
2) 4.98±1.59 4.33±1.41 6.89±1.79 7.51±0.81 <0.001
F area (mm
2) 2.22±1.38 1.27±0.68 3.32±1.14 2.99±0.60 0.001
FF area (mm
2) 0.49±0.33 0.18±0.12 0.38±0.11 0.52±0.19 0.005
NC area (mm
2) 0.08±0.04 0.35±0.17 0.74±0.38 0.94±0.20 <0.001
DC area (mm
2) 0.07±0.06 0.11±0.09 0.32±0.15 0.88±0.23 <0.001
Plaque burden (%) 53.56±8.81 49.41±5.54 60.26±6.27 58.64±4.12 0.005
F percent (%) 76.29±8.38 68.33±13.34 70.39±4.93 54.85±5.61 0.001
FF percent (%) 17.37±8.09 7.87±3.29 8.37±2.29 9.37±3.49 <0.001
NC percent (%) 3.69±2.06 17.40±7.71 14.39±2.82 18.46±4.36 <0.001
DC percent (%) 2.65±3.34 6.38±7.74 6.85±2.89 17.24±3.82 <0.001
Table 2. Gray scale IVUS and VH-IVUS parameters in fibroatheromas
Fig. 2. Comparative VH-IVUS and microscopic findings between early fibroatheromas (FA) or late FAs and advanced FAs. Early FAs (A,
B) had smaller necrotic cores compared to advanced FAs (F, G) with larger lipid pools. Late FAs (C) had few calcium components, while
advanced FAs (H) had a large amount of calcium and decalcified empty spaces (arrows). The expression of CD68-positive macrophages
(arrows) was strong in advanced FA (I) rather than in late FA (D). MMP-9 activity (arrows) was also prominent in advanced FA (J) as opposed
to late FA (E). (B and G, H&E staining at ×40 magnification; C and H, von Kossa staining at ×40 and ×100 magnification, respectively;
D and I, CD68 immunohistochemical staining at ×100 magnification; E and J, MMP-9 immunohistochemical staining at ×100 magnifica-
tion).
A
F G H I J
B C D Ely by pathology and VH-IVUS. 
Expression of Nogo-B and correlation with plaque 
components
Immunohistochemical stainings for Nogo-B demonstrat-
ed that early FA had a diffuse expression of Nogo-B (as much
as the control). Nogo-B expression was weaker in late FA, but
not significantly weaker compared to that in early FA (P=
0.991). The expression of Nogo-B in advanced FA was much
weaker than that in early FA (P=0.013) or late FA (P=0.008). 
The immunohistochemical staining patterns of Nogo-B
in late or advanced FA were different from that in early FA.
Nogo-B was focally distributed in atherosclerotic plaques in
late and advanced FA (Fig. 5).
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Fig. 3. Quantitative graphs of necrotic cores, calcium, CD68-positive macrophages, and MMP-9 activity in various stages of FA.
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Values are means±SD. ANOVAR was used to compare data between
groups. P values <0.05 were considered statistically significant. 
FA, fibroatheroma; VH-IVUS, virtual histology intravascular ultrasound.
Early FA Late FA Advanced FA P value
VH-IVUS 0.08±0.04 0.35±0.17 0.80±0.33 <0.001
Pathology 0.08±0.09 0.15±0.23 2.19±1.57 <0.001
Table 3. Measurements of necrotic core areas (mm
2) by VH-IVUS
and pathology
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Fig. 4. The correlation of necrotic core area between VH-IVUS and
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There was a significant inverse relationship between Nogo-
B expression and both core necrosis area (r=-0.437, P=0.007)
and plaque area (r=-0.398, P=0.015, figure not shown here).
However, the relationship between Nogo-B expression and
the calcium component or age was not significant (r=-0.212,
P=0.209; r=0.038, P=0.821, respectively). In terms of the
inflammatory response of atherosclerosis, which not fully es-
tablished yet, there was a significant inverse correlation bet-
ween Nogo-B expression and CD68 activity (r=-0.377, P=
0.022), while not MMP-9 activity (r=-0.278, P=0.096)
(Fig. 6).
DISCUSSION
The present study demonstrated the inverse relation bet-
ween Nogo-B expression and FA progression in autopsied
coronary arteries. This is the first human study assessing the
correlation between Nogo-B and plaque composition ana-
lyzed by VH-IVUS. Our data revealed decreased expression
of Nogo-B in advanced FA, including vulnerable TCFA pla-
ques.
Nogo proteins are composed of three alternative splice forms:
1192-residue Nogo-A, 373-residue Nogo-B, and 199-residue
Nogo-C. Despite their significantly different N-terminal
lengths, they share a conserved C-terminal reticulon-homol-
ogy domain consisting of two transmembrane fragments, a
66-residue extracellular loop (Nogo-66) and a 38-residue C-
tail carrying an endoplasmic reticulum retention motif. Nogo-
A has the largest N-terminus (1016 residues), while Nogo-
B has an N-terminus almost identical to the first 200 residues
of Nogo-A (18).
Rodriguez-Feo et al. (21) previously reported that Nogo-B
levels in carotid plaques are inversely related with the pres-
ence of large lipid pools. However, they classified roughly two
groups based on a degree of carotid stenosis of 90% and a fat
content of 40%. This is insufficient to analyze the relation
between Nogo-B and plaque progression over time. 
We classified atherosclerotic plaques into 4 groups using
VH-IVUS. Early FA with NC area <0.1 mm2 and late FA
with NC area 0.1-1.0 mm2 were defined in the present study
based on a previous investigation by Virmani et al. (19). They
performed morphometric plaque analysis and suggested four
groups based on NC: pathologic intimal thickening without
NC, early core FA with NC area 0.06±0.02 mm2, late core
FA with NC area 0.84±0.08 mm2, and thin-cap atheroma. 
TkCFA and TCFA are widely used VH-IVUS plaque clas-
sifications since the pathologic confirmation based on these
classifications is very high, as the predictive accuracy is appro-
ximately 93.4% for fibrous, 94.6% for fibrofatty tissue, 95.1%
for NC, and 96.8% for dense calcium (22). However, vali-
dation of VH-IVUS has a controversy yet. An animal study
by Granada et al. demonstrated that the sensitivity of IVUS-
VH for the detection of fibrous, fibrofatty, and necrotic core
tissue was 76.1%, 46%, and 41.1% respectively (23). In the
present study, the correlation of NC and coincidence of FA
classification between VH-IVUS and pathology were 71%,
and 94% respectively. The study for validation and accuracy
of VH-IVUS will be needed more in future. 
Atherosclerotic plaques are caused by abnormal cellular
proliferation and migration, lipid deposition, and extracel-
lular matrix accumulation (24). Rupture-prone, vulnerable
TCFAs are associated with a high inflammatory component
and a large necrotic core accompanied by elevated proteolyt-
ic activity (1, 25).
VH-IVUS revealed that core necrosis and calcification were
more significant in advanced FA compared to early FA and
late FA. There have been many studies looking at the posi-
tive correlation between coronary artery calcification and athe-
rosclerosis progression or coronary artery disease (26-28). Pre-
vious data have shown that the N-terminal regions of both
Nogo-A and -B have a putative calcium binding site (18).
Therefore, we deduced that decreased expression of Nogo-B
proteins could play a role in coronary artery calcification. How-
Fig. 5. Nogo-B expression with plaque growth. Early fibroathero-
mas (FA) (B and F) showed diffuse Nogo-B expression (arrows)
comparable to that seen in controls (A and E). Late FAs (C and
G) had weaker, focal expression (arrows) of Nogo-B compared
to early FAs. Advanced FA (D and H) demonstrated much weak-
er focal Nogo-B activity (arrows) compared to that seen in early
FA or late FA. I, quantitative graphs of Nogo-B expression in vari-
ous FA stages. (Immunohistochemical staining for Nogo-B, A to
D, ×40 magnification, E to H, ×100 magnification).
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ever, our data showed that only three factors, such as plaque
burden, core necrosis, and CD68 activity, were significantly
negatively correlated with Nogo-B activity, while calcifica-
tion, age, and fibrosis were not related with Nogo-B expres-
sion. These findings imply that the principal pathology of
plaque progression and instability is increased core necrosis
and inflammation, rather than increased calcium deposition.
The role of calcium in atherosclerotic plaque progression is
more complicated than we initially thought it to be. 
We also found the expression pattern of Nogo-B to be in-
teresting. Diffuse Nogo-B distribution was noted in early FA
and in healthy arteries containing non-atherosclerotic plaques,
while focal distribution was noted in diseased arteries con-
taining atherosclerotic plaques, such as late FA and advanced
FA. The mechanism of this differing distribution pattern is
unclear, but some mechanisms have been proposed. One is
endothelial shear stress (29). Pressure, but not cellular stretch,
has been associated with Nogo-B up-regulation in nonvas-
cular cells. Low endothelial shear stress is a powerful local sti-
mulus for atherogenesis, as well as formation and progression
of early atherosclerotic plaques and differentiation of high-
risk plaques. Thus, high Nogo-B expression presents in heal-
thy arteries with continuous pulsatile and unidirectional endo-
thelial shear stress. Disturbed laminar flow develops, and the
pulsatile flow generates low and/or oscillatory endothelial
shear stress, which induces low Nogo-B expression. Anoth-
er possible mechanism is a complicated local inflammation,
which not fully established yet (30). Nogo-B expression was
significantly negatively correlated with CD68 activity, but
not with MMP-9 activity in the present study. Despite the
overall reduced Nogo-B levels in plaques, local accumulation
of Nogo-B is noted in macrophage-rich areas. Nogo-B also
seems to be concentrated in macrophages or foam cells. Hen-
ce, new materials inhibiting local inflammation and prevent-
ing Nogo-B reduction (e.g., through a Nogo-B eluting stent)
might be helpful in managing coronary artery disease in the
future.
There are several limitations to the present study. We could
not investigate circulating levels of Nogo-B. Thus, we could
not determine if it serves as a surrogate biomarker of human
atherosclerosis. Another limitation of our study is the rela-
tively small sample size. Furthermore, we could not exclude
Fig. 6. The correlation between immunohistochemical Nogo-B activity, and plaque composition and CD68/MMP-9 expression. Nogo-B ex-
pression carried a significant negative correlation with core necrosis (A), but not with calcification (B). Nogo-B expression had a significant
negative correlation with the number of CD68-positive cells (C), but not with MMP-9 expression (D).
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the effect of current medication or atherosclerotic risk factors,
such as diabetes, smoking, or hypercholesterolemia. How-
ever, the study population included subjects who suffered
non-cardiac deaths, such as motor vehicle injury, stab wound
injury, and fall injury. Hence, the study population appeared
to represent the general population, and we believe our data
accurately indicated the natural course of atherosclerosis and
its relation to Nogo-B.
In conclusion, the present study shows that Nogo-B expres-
sion is down-regulated and inversely correlated with FA pro-
gression. This is specifically represented by the increasing
size of the necrotic core. Our findings support the hypothe-
sis that local Nogo-B reduction may contribute to plaque
formation and/or vulnerability. 
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